Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more
Carl Zeiss Meditec AG (CZMWF) - Total Liabilities
Latest total liabilities as of September 2025: $1.28 Billion USD
Based on the latest financial reports, Carl Zeiss Meditec AG (CZMWF) has total liabilities worth $1.28 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Carl Zeiss Meditec AG - Total Liabilities Trend (2006–2025)
This chart illustrates how Carl Zeiss Meditec AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Carl Zeiss Meditec AG Competitors by Total Liabilities
The table below lists competitors of Carl Zeiss Meditec AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
EO Technics Co. Ltd
KQ:039030
|
Korea | ₩82.71 Billion |
|
L&F Co. Ltd
KQ:066970
|
Korea | ₩2.24 Trillion |
|
Western Securities Co Ltd
SHE:002673
|
China | CN¥80.68 Billion |
|
Liquidia Technologies Inc
NASDAQ:LQDA
|
USA | $253.93 Million |
|
Zhongfu Straits Pingtan Development Co Ltd
SHE:000592
|
China | CN¥1.32 Billion |
|
Guangdong Fenghua Advanced Technology Holding Co Ltd
SHE:000636
|
China | CN¥4.22 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Carl Zeiss Meditec AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Carl Zeiss Meditec AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Carl Zeiss Meditec AG (2006–2025)
The table below shows the annual total liabilities of Carl Zeiss Meditec AG from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $1.28 Billion | -4.57% |
| 2024-09-30 | $1.34 Billion | +55.43% |
| 2023-09-30 | $860.02 Million | +8.49% |
| 2022-09-30 | $792.73 Million | +10.32% |
| 2021-09-30 | $718.59 Million | +27.70% |
| 2020-09-30 | $562.73 Million | -7.01% |
| 2019-09-30 | $605.17 Million | +74.19% |
| 2018-09-30 | $347.42 Million | -8.90% |
| 2017-09-30 | $381.37 Million | -3.83% |
| 2016-09-30 | $396.57 Million | +16.01% |
| 2015-09-30 | $341.84 Million | +19.99% |
| 2014-09-30 | $284.88 Million | +15.93% |
| 2013-09-30 | $245.74 Million | -7.99% |
| 2012-09-30 | $267.08 Million | +14.42% |
| 2011-09-30 | $233.43 Million | -3.63% |
| 2010-09-30 | $242.22 Million | +12.87% |
| 2009-09-30 | $214.59 Million | -0.23% |
| 2008-09-30 | $215.09 Million | +0.02% |
| 2007-09-30 | $215.06 Million | +39.41% |
| 2006-09-30 | $154.27 Million | -- |